These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
25. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]. Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905 [TBL] [Abstract][Full Text] [Related]
26. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773 [TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease. Brusamolino E; Lazzarino M; Morra E; Inverardi D; Merante S; Castelli G; Canevari A; Dornini G; Bernasconi C Haematologica; 1989; 74(2):173-9. PubMed ID: 2473013 [TBL] [Abstract][Full Text] [Related]
28. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
29. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863 [TBL] [Abstract][Full Text] [Related]
30. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP? Hehn ST; Miller TP Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845 [TBL] [Abstract][Full Text] [Related]
31. Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy. Bonadonna G; Valagussa P; Santoro A Cancer Surv; 1985; 4(2):439-58. PubMed ID: 2430700 [TBL] [Abstract][Full Text] [Related]
32. Should MOPP-ABVD alone be standard for childhood Hodgkin's? Constine LS J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214 [No Abstract] [Full Text] [Related]
33. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. Martinelli G; Cocorocchio E; Peccatori F; Zucca E; Saletti PC; Calabrese L; Pastano R; Pruneri G; Mazzetta C; Ghielmini M; Cavalli F Br J Haematol; 2004 Jun; 125(5):584-9. PubMed ID: 15147373 [TBL] [Abstract][Full Text] [Related]
34. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
35. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results. Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855 [No Abstract] [Full Text] [Related]
36. [Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation]. Leverger G; Oberlin O; Schaison G; Lemerle J Nouv Rev Fr Hematol (1978); 1987; 29(1):83-5. PubMed ID: 2438648 [TBL] [Abstract][Full Text] [Related]
37. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD? Canellos GP Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055 [No Abstract] [Full Text] [Related]
38. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. Klimo P; Connors JM Semin Hematol; 1988 Apr; 25(2 Suppl 2):34-40. PubMed ID: 2456621 [TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. Harker WG; Kushlan P; Rosenberg SA Ann Intern Med; 1984 Oct; 101(4):440-6. PubMed ID: 6206757 [TBL] [Abstract][Full Text] [Related]
40. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP. Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]